Sara Bustreo

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

Giovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti et al. · British Journal of Cancer · 2020 · 354 citations · Full text

Medicine, Immunology, Oncology +17

Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer

Ludovic Barault, Alessio Amatu, Giulia Siravegna et al. · Gut · 2017 · 238 citations · Full text

Medicine, Molecular Biology, Oncology +17

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up

Sara Bustreo, Simona Osella‐Abate, Paola Cassoni et al. · Breast Cancer Research and Treatment · 2016 · 229 citations · Full text

Medicine, Oncology, Breast Oncology +14

Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival

Marco Calandri, Suguru Yamashita, Carlo Gazzera et al. · European Radiology · 2018 · 126 citations

Medicine, Oncology, Surgery +17

Phase II study of preoperative (PREOP) chemoradiotherapy (CTRT) plus avelumab (AVE) in patients (PTS) with locally advanced rectal cancer (LARC): The AVANA study.

Lisa Salvatore, Maria Bensi, Salvatore Corallo et al. · Journal of Clinical Oncology · 2021 · 67 citations

Medicine, Immunology, Oncology +17